Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 25, 2023
Data Byte

Aggressive cuts part of Novartis’ focus on higher-potential pipeline

The pharma’s latest quarterly update revealed a pruning of 10% of its pipeline, including several early-stage cancer programs
BioCentury | Feb 23, 2023
Deals

Redx adds U.S. office while Jounce shareholders eye CVR’s upside in merger

Combined company will prioritize U.K. company’s ROCK2 program as deal adds to Redx’s balance sheet
BioCentury | Jul 11, 2019
Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

Why companies are turning to the tumor stroma to overcome resistance to checkpoint inhibitors
BioCentury | Oct 11, 2018
Distillery Therapeutics

Cancer

BioCentury | Aug 22, 2017
Distillery Therapeutics

Cancer

BioCentury | Feb 8, 2017
Distillery Therapeutics

Cardiovascular

Items per page:
1 - 9 of 9